A Research Study to Evaluate BLX-7006 in Healthy Adults

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

May 31, 2026

Conditions

Normal Healthy VolunteerSafety After Oral Intake

Interventions

DRUG

BLX-7006

BLX-7006 Single or Multiple doses administered orally as a tablet

DRUG

Placebo

Participants will receive matching placebo of BLX-7006 for each of the oral cohorts.

Trial Locations (1)

Nucleus Network Brisbane Clinic, Brisbane